Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001725160-24-000163)

Filing Details

Accession Number:: 0001725160-24-000163
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-04 18:01:21
Reporting Period:: 2024-10-04

Accepted Time:: 2024-10-04 18:01:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1725160	Zentalis Pharmaceuticals Inc.	ZNTL	Pharmaceutical Preparations (2834)	823607803

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2018766	Vincent Vultaggio	C/O Zentalis Pharmaceuticals, Inc. 10275 Science Center Drive, Suite 200 San Diego CA 92121	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-10-04	1,603	$3.18	33,855	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

A portion of the shares were sold automatically to satisfy withholding tax obligations upon the vesting of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on September 20, 2023.